Anthropic的Fable 5模型原计划开放测试至6月22日,后被移除计划。用户反映其护栏极其严格,连最简单问题也会被立即切断。从商业角度看,此举契合Anthropic即将到来的IPO:通过展示Fable 5在生物学和药物研发方面的先进能力(将内部蛋白质设计专家的药物设计流程加速约10倍),向企业客户证明其模型性能顶尖,从而吸引更高定价和收入。作者认为这标志着加速科学再度临近。
Being able to test Fable 5 until June 22nd, only to have it removed from the plans, feels like getting a sneak peek and then having the food taken away from the table.
But from a business perspective, it makes perfect sense for Anthropic and its upcoming IPO: It demonstrates how advanced Anthropic is, how good its models are (the blog post refers to biology and research), and especially in the enterprise sector, companies often want the best model, which is also more expensive.
Therefore, it will generate even more revenue for the company.
But admittedly, the fact that Anthropic was able to accelerate "internal protein design experts aspects of the drug design process by around ten times" is extremely impressive.
We are once again on the cusp of accelerated science. The next few years are going to be crazy.